GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
234 hedge funds and large institutions have $4.73B invested in Global Blood Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 77 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
24% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 62
13% more funds holding
Funds holding: 208 → 234 (+26)
Holders
234
Holding in Top 10
8
Calls
$174M
Puts
$64M
Top Buyers
| 1 | +$91.9M | |
| 2 | +$85.6M | |
| 3 | +$58M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$43.7M |
| 5 |
Millennium Management
New York
|
+$15.4M |
Top Sellers
| 1 | -$72.1M | |
| 2 | -$68.5M | |
| 3 | -$68M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$48.5M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$32.2M |